Dr. Jacqueline Denise Moylan, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 15 Alliance St, New Philadelphia, PA 17959 Phone: 570-127-7621 Fax: 570-277-6398 |
News Archive
Siemens Healthcare has achieved Complete EHR ONC-ATCB 2011/2012 Certification for Soarian® EHR version 2010, INVISION® EHR version 2010 and MedSeries4® EHR version 2010. These Complete EHRs are 2011/2012 compliant and have been certified by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable certification criteria for Hospitals adopted by the Secretary of Health and Human Services.
Concert Pharmaceuticals, Inc. today announced 48-week results of its Phase 2 clinical trial of CTP-499 in patients with diabetic kidney disease. CTP-499, when used in addition to the standard of care, is being developed to delay the progression of these patients to end-stage renal failure, which requires dialysis or kidney transplantation.
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.
Healthcare professionals now have a new OTC (over- the-counter) product designed for the 2 in 5 Americans the Centers for Disease Control and Prevention (CDC) now estimates will develop Type-2 diabetes in their lifetime – Glucose Health Natural Blood Sugar Maintenance.
Australian researchers have found that people suffering with lower back pain can significantly reduce their pain and disability by learning to control their trunk muscles.
› Verified 4 days ago